BP
REGN icon

Banyan Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Banyan Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$592K Sell
1,643
-35
-2% -$11.7K 0.05% 280
2014
Q2 		$474K Buy
1,678
+5
+0.3% +$1.48K 0.04% 316
2014
Q1 		$503K Sell
1,673
-45
-3% -$13.9K 0.04% 298
2013
Q4 		$473K Buy
1,718
+1,018
+145% +$293K 0.03% 314
2013
Q3 		$219K Buy
+700
New +$184K 0.02% 310

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Banyan Partners's REGN Position: Q3 2014 in Review

Banyan Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q3 2014, selling an estimated $11.7K and leaving 1,643 shares worth $592K. The position accounts for 0.05% of the portfolio, ranked #280.

Banyan Partners first reported a position in REGN in Q3 2013 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold REGN as of Q3 2014.

  • Banyan Partners held 1,643 shares of Regeneron Pharmaceuticals worth $592K as of Q3 2014.
  • Banyan Partners sold 35 Regeneron Pharmaceuticals shares in Q3 2014, an estimated $11.7K.
  • Regeneron Pharmaceuticals made up 0.05% of Banyan Partners's portfolio in Q3 2014, its #280 holding.
  • Banyan Partners first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 5 quarters since.
  • 474 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.